Reductions in optic disc microvasculature are associated with visual field progression in patients with primary open-angle glaucoma.

Haptic devices are being used in Portland, Sacramento and Phoenix to assist visually impaired fans in experiencing NBA games ...

However, without the U.S. Department of Education, the National Center for Education Statistics (NCES) will be lost, which will have an especially negative impact on low-income schools ...

Singer-actresses Tasha Low and Ferlyn Wong join actress Chantalle Ng to form the trio of new “little Nyonyas” in the 30-part series, a spin-off and loose sequel to Channel 8’s massive 2008 ...

Chief Executive Officer Tim Cook has lost confidence in the ability of AI head John Giannandrea to execute on product development, so he’s moving over another top executive to help: Vision Pro creator ...

Many lifestyle and medical factors can cause low energy, including anemia, low testosterone, and an unbalanced diet. Some causes are unique to males or are more common in males than females.

The pain may begin around the eye or temple and then spread across the head. Some other symptoms of migraine include: changes to vision nausea and vomiting dizziness extreme sensitivity to sound ...

the current VP of the Vision Products Group (the team behind the Vision Pro), to head up the Siri team. The report indicates Cook has “lost confidence” in the current AI head, John Giannandrea ...

Vision Pro hardware engineer Paul Meade will be succeeding Rockwell as the head of Apple's spatial computing efforts, allowing Rockwell to focus entirely on Siri, according to the report.

Mike Rockwell, vice president in charge of the Vision Products Group, will now be in charge of the iPhone maker's Siri virtual assistant as CEO Tim Cook has lost confidence in AI head John ...

Low-income households, who spend a larger share of their budgets on goods than the wealthy and tend to favor cheaper imports, will bear the brunt of the hit. Economists from Bank of America and ...

No­vo Nordisk’s late-stage weight loss da­ta showed Ca­griSe­ma per­formed be­low an­a­lysts’ ex­pec­ta­tions. It’s the sec­ond late-stage clin­i­cal let­down for the can­di ...